Skip to content
Latest
Jeremy Gillis Announces Further Acquisition Of Common Shares Of Northern Lights Resources Corp. StickIt Announces Notice Of Proposed Consolidation WesCan Energy Reports Second Quarter Fiscal 2027 Results: Second Consecutive Profitable Quarter and Higher Year-over-Year Cash Flow Lincoln Gold Announces Upgrade to OTCQB Venture Market, Expanding U.S. Investor Access Allarta Life Science moves Canadian-developed type 1 diabetes cell therapy closer to the clinic with Breakthrough T1D award ZincX Retains Market-Making Services Water Tower Research Publishes Initiation of Coverage Report on Ingevity Corporation, “High-Margin Carbon Franchise Riding a Structural Shift to Hybrids with PFAS Upside” Canam Biotech Announces Effective Date for Spinout of 1207331 B.C. Ltd. Jeremy Gillis Announces Further Acquisition Of Common Shares Of Northern Lights Resources Corp. StickIt Announces Notice Of Proposed Consolidation WesCan Energy Reports Second Quarter Fiscal 2027 Results: Second Consecutive Profitable Quarter and Higher Year-over-Year Cash Flow Lincoln Gold Announces Upgrade to OTCQB Venture Market, Expanding U.S. Investor Access Allarta Life Science moves Canadian-developed type 1 diabetes cell therapy closer to the clinic with Breakthrough T1D award ZincX Retains Market-Making Services Water Tower Research Publishes Initiation of Coverage Report on Ingevity Corporation, “High-Margin Carbon Franchise Riding a Structural Shift to Hybrids with PFAS Upside” Canam Biotech Announces Effective Date for Spinout of 1207331 B.C. Ltd.
STOX.NEWS
In focus

Canam Biotech Announces Effective Date for Spinout of 1207331 B.C. Ltd.

Image supplied by TheNewswire.
Advertisement
Demo creative for ADG7 Article top (728x90)

Vancouver, B.C., November 17, 2026 – TheNewswire – Canam Biotech Inc. (the “Company”) is pleased to announce that it set the effective date as November 16, 2026 (the “Effective Date”) for the spinout of 1207331 B.C. Ltd. (“331BC”), a wholly owned subsidiary of the Company formed to conduct a transaction under its 2019 plan of arrangement (the “Arrangement”).

 

Under the Arrangement, the effective date for the Arrangement can be set separately as between the Company and each of the other parties to the Arrangement. The  share distribution record date for the Arrangement as between the Company and 331BC was set to the end of business day on November 4, 2026 (as previously announced through a press release by the Company), which is the record date of the shareholders of the Company who would be entitled to receive shares of  331BC on the effectiveness of the Arrangement as between the Company and 331BC.  The Company’s shareholders of record as of November 4, 2026 eligible to receive shares of 331BC under the Arrangement received a total of 551,634 common shares of 331BC, subject to rounding down for any fractional shares, with a fair value of $0.001813 per share and $1,000 aggregate value issued effective November 16, 2026.

 

About the Company

Canam Biotech Inc. is an early-stage biotech company looking to acquire or develop commercial products and/or technology in Canada.

 

For further information please contact:

J. Scott Munro, CEO

E-mail: admin@munrofinancial.ca  

Cautionary Note Regarding Forward Looking Information

 

This press release contains projections and forward-looking information that involve various risks and uncertainties regarding future events. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of the Company. There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company assumes no obligation to update forward-looking information should circumstances or management’s estimates or opinions change.

Copyright (c) 2026 TheNewswire – All rights reserved.

Advertisement
Demo creative for ADG8 Article body (336x280)

More on this